tiprankstipranks
Advertisement
Advertisement

KSPHF Stock Latest News

Kissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
Company AnnouncementsKissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
5d ago
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
PremiumCompany Announcements
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
12d ago
Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
PremiumCompany Announcements
Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
2M ago
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
PremiumCompany Announcements
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
2M ago
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
PremiumCompany Announcements
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
3M ago
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
PremiumCompany AnnouncementsKissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
3M ago
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
Premium
Company Announcements
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
3M ago
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
3M ago
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
PremiumCompany Announcements
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
5M ago
Kissei Pharmaceutical initiated with a Neutral at UBS
PremiumThe Fly
Kissei Pharmaceutical initiated with a Neutral at UBS
5M ago
Kissei Pharmaceutical Adjusts Dividend Payment Date
PremiumCompany Announcements
Kissei Pharmaceutical Adjusts Dividend Payment Date
5M ago
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
PremiumCompany Announcements
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
6M ago
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
PremiumCompany AnnouncementsKissei Pharmaceutical Revises Financial Forecast with Positive Outlook
6M ago
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
Premium
Company Announcements
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
6M ago
Kissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Kissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet
6M ago
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
PremiumCompany Announcements
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
6M ago
KSPHF
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
PremiumCompany Announcements
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
6M ago
KSPHF
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
PremiumCompany Announcements
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
6M ago
KSPHF
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
PremiumCompany Announcements
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
6M ago
KSPHF
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
PremiumCompany AnnouncementsKissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
6M ago
KSPHF
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
Premium
Company Announcements
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
7M ago
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
Premium
Company Announcements
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >